BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36647850)

  • 1. Ferroptosis in neurodegenerative diseases: inhibitors as promising candidate mitigators.
    Zhang RF; Zeng M; Lv N; Wang LM; Yang QY; Gan JL; Li HH; Yu B; Jiang XJ; Yang L
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):46-65. PubMed ID: 36647850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.
    Zhou J; Jin Y; Lei Y; Liu T; Wan Z; Meng H; Wang H
    Neurodegener Dis; 2020; 20(1):20-34. PubMed ID: 32814328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology.
    Wang Y; Tang B; Zhu J; Yu J; Hui J; Xia S; Ji J
    Int J Biol Sci; 2022; 18(10):4260-4274. PubMed ID: 35844784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases.
    Wang Y; Li H; He Q; Zou R; Cai J; Zhang L
    Apoptosis; 2024 Feb; 29(1-2):3-21. PubMed ID: 37848673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Ferroptosis in Diseases.
    Qiu Y; Cao Y; Cao W; Jia Y; Lu N
    Pharmacol Res; 2020 Sep; 159():104919. PubMed ID: 32464324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ferroptosis opens new avenues for the development of novel therapeutics.
    Sun S; Shen J; Jiang J; Wang F; Min J
    Signal Transduct Target Ther; 2023 Sep; 8(1):372. PubMed ID: 37735472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis.
    Liu Z; Lv X; Song E; Song Y
    Toxicol Appl Pharmacol; 2020 Nov; 407():115241. PubMed ID: 32937103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lipid metabolism for ferroptotic cancer therapy.
    Luo M; Yan J; Hu X; Li H; Li H; Liu Q; Chen Y; Zou Z
    Apoptosis; 2023 Feb; 28(1-2):81-107. PubMed ID: 36399287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease.
    Lin KJ; Chen SD; Lin KL; Liou CW; Lan MY; Chuang YC; Wang PW; Lee JJ; Wang FS; Lin HY; Lin TK
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.
    Wu L; Xian X; Tan Z; Dong F; Xu G; Zhang M; Zhang F
    Mol Neurobiol; 2023 May; 60(5):2832-2850. PubMed ID: 36735178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease.
    Fan X; Li A; Yan Z; Geng X; Lian L; Lv H; Gao D; Zhang J
    Oxid Med Cell Longev; 2022; 2022():6291889. PubMed ID: 35993022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
    Maru D; Hothi A; Bagariya C; Kumar A
    Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal.
    Nishizawa H; Yamanaka M; Igarashi K
    FEBS J; 2023 Apr; 290(7):1688-1704. PubMed ID: 35107212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of Ferroptosis in Ischemic Stroke and Therapeutic Targets.
    Tian X; Li X; Pan M; Yang LZ; Li Y; Fang W
    Cell Mol Neurobiol; 2024 Feb; 44(1):25. PubMed ID: 38393376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic inhibition of ferroptosis in neurodegenerative disease.
    Ryan SK; Ugalde CL; Rolland AS; Skidmore J; Devos D; Hammond TR
    Trends Pharmacol Sci; 2023 Oct; 44(10):674-688. PubMed ID: 37657967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response.
    Zhou Y; Chen Z; Yang M; Chen F; Yin J; Zhang Y; Zhou X; Sun X; Ni Z; Chen L; Lv Q; Zhu F; Liu S
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38742521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
    Viktorinova A; Durfinova M
    Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics.
    Li Z; Zhang Y; Ji M; Wu C; Zhang Y; Ji S
    Biomed Pharmacother; 2024 Jul; 176():116777. PubMed ID: 38795640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PM2.5 induces ferroptosis in human endothelial cells through iron overload and redox imbalance.
    Wang Y; Tang M
    Environ Pollut; 2019 Nov; 254(Pt A):112937. PubMed ID: 31401526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis: A New Development Trend in Periodontitis.
    Chen K; Ma S; Deng J; Jiang X; Ma F; Li Z
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.